Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Metals One

    MCap

    —

    Last close

    GBP0.01

    ▲ 0.18 (19.44%)

    Circio Holding

    MCap

    NOK2,522m

    Last close

    NOK10.92

    ▲ 1.74 (18.95%)

    LM PAY

    MCap

    EUR24m

    Last close

    EUR37.60

    ▲ 4.00 (11.90%)

  • Sectors

    Sectors

  • Megatrends

    Megatrends

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Sparks commentary

Healthcare

Sparks

Isofol Medical (ST: ISOFOL) completes pre-IND meeting for arfolitixorin
Published by Arron Aatkar, PhD

Isofol Medical has announced the completion of a pre-IND meeting with the FDA for arfolitixorin. According to management, the meeting was a success, with the FDA providing positive feedback on the company’s clinical development plan for the candidate. This is an important milestone for Isofol, as it provides a foundation for further development efforts and potential eventual commercialisation in the US.

Isofol is currently evaluating arfolitixorin in a Phase Ib/II trial as a potential treatment for patients with metastatic colorectal cancer.

Next Sparks Commentary in this sector >

Latest

Healthcare | Comment

Mendus (OMX: IMMU) – CML momentum builds (Q226 results)

Healthcare | Comment

Herantis Pharma (HEL: HRTIS) – Phase II preparations take centre stage (H126 results)

Healthcare | Comment

SynAct Pharma’s (STO:SYNACT) Q226 results highlight resomelagon progress

Healthcare | Comment

Percheron Therapeutics (ASX:PER) FY26 results broadly in line, HMBD-002 in Focus

Healthcare | Comment

Zelluna (OSE: ZLNA) clears first safety hurdle in ZIMA-101
Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.